“A Prospective, Randomized and Double Blind Once-Monthly Oral Ibandronate and Risedronate in Post-Menopausal Osteoporosis Leprosy Patients”. International Journal of Biomedical and Advance Research, vol. 8, no. 11, Nov. 2017, pp. 407-15, https://doi.org/10.7439/ijbar.v8i11.4474.